$mreo
MREO faces a class action lawsuit, yet social sentiment is up significantly, with posts highlighting potential bounce plays and buy-the-dip opportunities.
About $mreo
MREO is a biotechnology company focused on developing treatments for various diseases.
Insights
- $mreo sentiment is up 100% from the previous week.
- $mreo engagements is up 1661.16% from the previous week.
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [-----] +1,661%
[--] Month: [-------] -92%
[--] Months: [---------] +21%
[--] Year: [---------] -19%
1-Year High: [-------] on 2025-12-29
1-Year Low: [---] on 2026-02-08
Engagements by network (24h): YouTube: [--] TikTok: [--] X: [-----] Reddit: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [---] on 2025-12-30
1-Year Low: [--] on 2025-09-21
Mentions by network (24h): YouTube: [--] TikTok: [--] X: [--] Reddit: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $mreo in the last [--] hours which is up 45% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-12-30
1-Year Low: [--] on 2025-09-24
The most influential creators that mention $mreo in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @TedKaridis | [--] | [---] | [--] | [-----] |
| @BuyTheUgly | [--] | [--] | [--] | [--] |
| @ej23ny | [--] | [-----] | [--] | [--] |
| @BiopharmIQ | [--] | [------] | [--] | [--] |
| @goldchart2 | [--] | [---] | [--] | [--] |
Sentiment: 86%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 86%
Daily Average: 86%
[--] Week: 100% +50%
[--] Month: 100% +24%
[--] Months: 100% no change
[--] Year: 100% +20%
1-Year High: 100% on 2025-02-21
1-Year Low: 33% on 2025-04-07
Most Supportive Themes:
- Potential Bounce Plays: (33%) Posts suggest MREO is being considered as a potential bounce play, similar to other stocks like IOBT, following periods of negative performance or bad results.
- Buy the Dip Signals: (17%) MREO was listed as a 'buy the dip' signal on February 6, 2026, indicating a potential buying opportunity for investors.
Most Critical Themes:
- Class Action Lawsuit: (50%) A class action lawsuit has been filed against Mereo BioPharma Group plc for investors who acquired their American Depositary Shares between June 5, 2023, and December 26, [----].
Top $mreo Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$MREO Although setback 2ndary Setru endpoint data ++. $RARE CEO has confirmed not dead. Will resubmit at some point after positive approval angle is calculated due to unmet need. Now probably best time to buy. 5-10x if this occurs"
X Link @TedKaridis 2026-02-14T14:44Z [---] followers, [---] engagements
"@1nvestorGadget $MREO $RARE time for them to get Senu [---] off the shelf and approved via BMD. Durg and manufacturing work with no issues unlike UX -111"
X Link @Heatlamp11 2026-02-14T13:15Z [---] followers, [---] engagements
"@FeldtInvesting News of a DSK departure would have $mreo pump"
X Link @westieofwallst 2026-02-13T09:05Z [---] followers, [---] engagements
"Biotech names forecasting huge revenue expansion next year: $MREO (+6363%) developing therapies for rare diseases and oncology with a focus on unmet medical needs. $DNLI (+3897%) targeting neurodegenerative conditions like Parkinsons and Alzheimers disease. $NTRB (+3394%) working on abuse-deterrent transdermal treatments and innovative drug delivery solutions. Big science. Big numbers. Big risk. https://twitter.com/i/web/status/2021625599291240816 https://twitter.com/i/web/status/2021625599291240816"
X Link @OceanBlueInvest 2026-02-11T16:41Z [--] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing